-
Ignacio Labayen de Inza—helping people face the dark world of chemsex Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Tony Kirby
-
-
-
Cognitive dysfunction in functional seizures: a neurologist's perspective Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Ingrid Hoeritzauer
-
Treatment paradigms for treatment-resistant schizophrenia Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Carol Lim, Abigail L Donovan
-
Using mental health policy to combat terrorism in Nigeria Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Taiwo Opekitan Afe, Olawale Ogunsemi, Blessing Afe
-
De-implementation to reduce coercive practices in mental health care Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Sophie Sergerie-Richard, Marie-Hélène Goulet, Alexandre Dumais, Catherine Hinse, Guillaume Fontaine
-
Psychological and psychosocial interventions for treatment-resistant schizophrenia: a systematic review and network meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Nurul Husna Salahuddin MSc, Alexandra Schütz MSc, Gabi Pitschel-Walz PhD, Susanna Franziska Mayer MSc, Anna Chaimani PhD, Spyridon Siafis MD, Prof Josef Priller PhD, Prof Stefan Leucht MD, Irene Bighelli PhD
Many patients with schizophrenia have symptoms that do not respond to antipsychotics. This condition is called treatment-resistant schizophrenia and has not received specific attention as opposed to general schizophrenia. Psychological and psychosocial interventions as an add-on treatment to pharmacotherapy could be useful, but their role and comparative efficacy to each other and to standard care
-
Cognitive performance in functional seizures compared with epilepsy and healthy controls: a systematic review and meta analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-13 Ryan Van Patten PhD, Tara A Austin PhD, Erica Cotton PsyD, Lawrence Chan PsyD, John A Bellone PhD, Kristen Mordecai PhD, Hamada Altalib MD, Stephen Correia PhD, Elizabeth W Twamley PhD, Richard N Jones ScD, Kelsey Sawyer MS, W Curt LaFrance Jr MD MPH
Cognition is a core component of functional seizures, but the literature on cognition in this disorder has been heterogeneous, with no clear unifying profile emerging from individual studies. The aim of this study was to do a systematic review and meta-analysis of cognitive performance in adults with functional seizures compared with epilepsy (including left temporal lobe epilepsy) and compared with
-
Discontinuation symptoms of antidepressants Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-05 Glyn Lewis, Gemma Lewis
-
Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-06-05 Jonathan Henssler MD, Yannick Schmidt MD, Urszula Schmidt MD, Guido Schwarzer PhD, Prof Tom Bschor MD, Prof Christopher Baethge MD
Antidepressant discontinuation symptoms are becoming an increasingly important part of clinical practice, but the incidence of antidepressant discontinuation symptoms has not been quantified. An estimate of antidepressant discontinuation symptoms incidence could inform patients and clinicians in the discontinuation of treatment, and provide useful information to researchers in antidepressant treatments
-
Preventing suicide in people who experience incarceration Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-29 Stuart A Kinner, Maha Aon, Rohan Borschmann
-
Worldwide incidence of suicides in prison: a systematic review with meta-regression analyses Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-29 Prof Adrian P Mundt PhD, Pablo A Cifuentes-Gramajo PhD, Gergő Baranyi PhD, Prof Seena Fazel PhD
Suicide is a leading cause of death during imprisonment. This systematic review aimed to synthesise available evidence of prison suicide incidence worldwide. We systematically searched the scientific literature, data repositories, and prison system reports, supplemented by correspondence with prison administrations. We included reports on people living in prison but excluded studies in preselected
-
Psychosis as a disorder of muscarinic signalling: psychopathology and pharmacology Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-22 Robert A McCutcheon MRCPsych PhD, Lilian A E Weber PhD, Matthew M Nour MRCPsych PhD, Prof Stephanie J Cragg DPhil, Prof Philip M McGuire FRCPsych PhD
Dopaminergic receptor antagonism is a crucial component of all licensed treatments for psychosis, and dopamine dysfunction has been central to pathophysiological models of psychotic symptoms. Some clinical trials, however, indicate that drugs that act through muscarinic receptor agonism can also be effective in treating psychosis, potentially implicating muscarinic abnormalities in the pathophysiology
-
10 years of The Lancet Psychiatry Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 The Lancet Psychiatry
-
Naming and coming to terms with bipolar hypersexuality Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Anne Chataigné
-
-
Perspectives on adolescent mental health after the COVID-19 pandemic Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Christian Hakulinen, Kaisla Komulainen
-
Breaking boxes: announcing the Lancet Psychiatry Commission on Lived Experience in Mental Health Research Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Laura Fischer, Sullivan Holderbach, Hanna Kienzler, Dylan Reddish, Lou Robbin, Angela Sweeney
-
Omission of mental health lived-experience research in implementation research commission Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Victoria J Palmer, Michelle Banfield
-
Opioid agonist treatment in Iran after an opium poppy ban in Afghanistan Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Bijan Pirnia
-
Suicide among medical residents in Iran Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Bijan Pirnia
-
Mental health after the COVID-19 pandemic among Finnish youth: a repeated, cross-sectional, population-based study Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Olli Kiviruusu PhD, Klaus Ranta MD PhD, Maija Lindgren PhD, Henna Haravuori MD PhD, Yasmina Silén MD PhD, Sebastian Therman PhD, Jukka Lehtonen PhD, Laura Sares-Jäske PhD, Terhi Aalto-Setälä MD PhD, Prof Mauri Marttunen MD PhD, Prof Jaana Suvisaari MD PhD
High levels of mental health problems among young people were reported during the COVID-19 pandemic, but studies of the post-pandemic period are scarce. We assessed mental health problems among Finnish youth before, during, and after the COVID-19 pandemic using nationwide population-based samples. Our aim was to examine in which direction the heightened levels of adolescent mental health problems have
-
Hypersexuality in bipolar disorder: an overlooked symptom Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-15 Clare Dolman, Louise Howard, Guy M Goodwin, Allan Young, Ian R Jones, Veerle Bergink, Thomas Richardson, Arianna Di Florio
-
School-based interventions to support mental health in adolescents: what works BESST? Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-14 Deborah M Caldwell
-
Clinical effectiveness and cost-effectiveness of a brief accessible cognitive behavioural therapy programme for stress in school-aged adolescents (BESST): a cluster randomised controlled trial in the UK Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-14 June Brown DClin Psy, Kirsty James MSc, Stephen Lisk PhD, James Shearer PhD, Prof Sarah Byford PhD, Prof Paul Stallard PhD, Prof Jessica Deighton PhD, David Saunders PhD, Jynna Yarrum MSc, Prof Peter Fonagy PhD, Timothy Weaver PhD, Irene Sclare DClin Psy, Crispin Day DClin Psy, Claire Evans MSc, Prof Ben Carter PhD
Depression and anxiety are increasingly prevalent in adolescents. The Brief Educational Workshops in Secondary Schools Trial investigated the effectiveness of a brief accessible stress workshop programme for 16–18-year-olds. We aimed to investigate the clinical effectiveness and cost-effectiveness of the DISCOVER cognitive behavioural therapy (CBT) workshop on symptoms of depression in 16–18-year-olds
-
Suicide prevention: reflections on progress over the past decade Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-13 Prof Keith Hawton FMedSci, Prof Jane Pirkis PhD
Interest in preventing suicides has increased greatly in recent years. In this Personal View, we consider the general global developments related to suicide prevention that have occurred in the decade since was first published in 2014. We then review specific advances during this period, first, in relation to public health initiatives, and second, with regard to clinical developments. Finally, we examine
-
Predictive coding and phenomenological approaches of delusions: convergence and differences – Authors' reply Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-02 Jessica Niamh Harding, Noham Wolpe, Stefan Peter Brugger, Victor Navarro, Christoph Teufel, Paul Charles Fletcher
-
Target trial emulation in psychiatry: a call for more rigorous observational analyses Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-02 Alejandro G Szmulewicz
-
Predictive coding and phenomenological approaches of delusions: convergence and differences Lancet Psychiatry (IF 30.8) Pub Date : 2024-05-02 Jasper Feyaerts, Rosa Ritunnano, Gert Jensen, Louis Sass
-
Does the evidence now suggest we can safely reduce the frequency of haematological monitoring for patients stabilised on clozapine? Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-30 Jack B Fanshawe, Belinda R Lennox
-
Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case–control study in Finland Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-30 Jose M Rubio MD, John M Kane MD, Antti Tanskanen PhD, Jari Tiihonen MD, Heidi Taipale PhD
Agranulocytosis is a life-threatening side-effect of clozapine, the only approved drug for treatment-resistant schizophrenia. The long-term profile of this complication has not yet been well established. Here we aim to describe the risk of clozapine-induced agranulocytosis over the long term. We used the entire population of Finland to identify people diagnosed with schizophrenia or schizoaffective
-
Engaging in healthy life activities is inherently valuable Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-23 Helene Speyer, Jim van Os
-
A transdiagnostic group exercise intervention for mental health outpatients in Germany (ImPuls): results of a pragmatic, multisite, block-randomised, phase 3 controlled trial Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-23 Sebastian Wolf PhD, Britta Seiffer MSc, Johanna-Marie Zeibig PhD, Anna Katharina Frei MSc, Thomas Studnitz MSc, Jana Welkerling MSc, Edith Meinzinger BSc, Leonie Louisa Bauer MSc, Julia Baur PhD, Stephanie Rosenstiel PhD, David Victor Fiedler MSc, Florian Helmhold MSc, Andreas Ray PhD, Eva Herzog MSc, Keisuke Takano PhD, Tristan Nakagawa PhD, Mia Maria Günak MSc, Saskia Kropp MSc, Stefan Peters PhD
Globally, mental health conditions pose a substantial burden of disease. Despite the availability of evidence-based pharmacological and psychological treatments, the symptoms of a substantial subgroup of patients do not respond to these interventions, and only a minority of patients have access to them. This study aimed to assess the efficacy of ImPuls, a 6-month transdiagnostic group exercise intervention
-
-
Absence of funding for pharmacotherapy for adults with ADHD in Poland Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-20 Daniel Pankowski, Kinga Wytrychiewicz-Pankowska
-
Does it matter if there are errors in GHQ-12 response items? Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-20 Bethany Croak, Neil Greenberg, Danielle Lamb, Sharon A M Stevelink, Simon Wessely
-
Staging 2.0: refining transdiagnostic clinical staging frameworks to enhance reliability and utility for youth mental health Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-18 Prof Jan Scott MD, Frank Iorfino PhD, William Capon MBMSc, Jacob Crouse PhD, Barnaby Nelson PhD, Andrew M Chanen PhD, Dominic Dwyer PhD, Philippe Conus MD, Andreas Bechdolf PhD, Aswin Ratheesh PhD, Andrea Raballo PhD, Alison Yung PhD, Michael Berk PhD, Sarah McKenna PhD, Samuel Hockey BoC, Alexis Hutcheon, Elizabeth Scott DM, Pat McGorry MD, Jai Shah PhD, Ian B Hickie MD
Globally, 75% of depressive, bipolar, and psychotic disorders emerge by age 25 years. However, these disorders are often preceded by non-specific symptoms or attenuated clinical syndromes. Difficulties in determining optimal treatment interventions for these emerging mental disorders, and uncertainties about accounting for co-occurring psychopathology and illness trajectories, have led many youth mental
-
The challenges at the core of multimorbidity research Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-17 Oleguer Plana-Ripoll, Danni Chen, Lisbeth Mølgaard Laustsen, Natalie C Momen
-
Prevalence of multimorbidity in people with and without severe mental illness: a systematic review and meta-analysis Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-17 Sean Halstead MD, Chester Cao MD, Grímur Høgnason Mohr MD, Prof Bjørn H Ebdrup MD PhD, Toby Pillinger PhD, Robert A McCutcheon PhD, Joseph Firth PhD, Prof Dan Siskind PhD, Nicola Warren PhD
People with severe mental illness, such as schizophrenia-spectrum disorder and bipolar disorder, face poorer health outcomes from multiple chronic illnesses. Physical multimorbidity, the coexistence of two or more chronic physical conditions, and psychiatric multimorbidity, the coexistence of three or more psychiatric disorders, are both emerging concepts useful in conceptualising disease burden. However
-
Establishing registry-based mental health research in Latin America Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 Franco Mascayano, Viviana Hernández, Lawrence Yang, Ezra Susser
-
Unregulated social media as a toxin: New York City's public health action Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 Nathaniel Z Counts, Deepa Avula, Ashwin Vasan
-
From clinical psychiatry to implementation research and back again Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 The Lancet Psychiatry
-
-
Non-fatal suicide behaviours: recommendations for addressing mental health Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 Clara González-Sanguino, Berta Ausín Benito, Manuel Muñoz López
-
Climate change and mental health: a call for a global research agenda Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 Amruta Nori-Sarma, Sandro Galea
-
Heat and hospital admission via the emergency department for people with intellectual disability, autism, and mental disorders in South Korea: a nationwide, time-stratified, case-crossover study Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 Jinah Park MPH, Ayoung Kim BSc, Prof Michelle L Bell PhD, Prof Ho Kim PhD, Prof Whanhee Lee PhD
Given the anticipated increase in ambient temperature due to climate change, the hazardous effects of heat on health have been extensively studied; however, its impact on people with intellectual disability, autism, and mental illness is largely unknown. We aimed to estimate the association between heat and hospitalisation through the emergency department (ED) among people with these mental disorders
-
Non-fatal suicide behaviours across phases in the COVID-19 pandemic: a population-based study in a Catalan cohort Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-15 Víctor Serrano-Gimeno MD, Alba Diestre MD, Marina Agustin-Alcain MD, Maria J Portella PhD, Javier de Diego-Adeliño MD PhD, Thaïs Tiana PsyD, Nora Cheddi MD, Alejandro Distefano MD, Guillermo Dominguez MD, Marina Arias MMath, Victor Cardoner MMath, Dolors Puigdemont MD PhD, Prof Victor Perez MD PhD, Prof Narcís Cardoner MD PhD
The COVID-19 pandemic has been extensively discussed in the context of its effect on mental health. Although global suicide rates have remained stable during the pandemic, the specific effect on non-fatal suicide behaviours during and after the pandemic remains underexplored. This study aims to investigate patterns of non-fatal suicide behaviours before, during, and after the pandemic. In this cohort
-
Standard guidelines on electronic mental health and psychosocial support for humanitarian assistance Lancet Psychiatry (IF 30.8) Pub Date : 2024-04-03 Darya Rostam Ahmed, Reinhard Heun
-
Health economics of psychological interventions in PTSD Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-27 Judith Dams
-
Cost-effectiveness of therapist-assisted internet-delivered psychological therapies for PTSD differing in trauma focus in England: an economic evaluation based on the STOP-PTSD trial Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-27 Ed Penington MSc, Prof Jennifer Wild DClinPsy, Emma Warnock-Parkes DClinPsy, Nick Grey DclinPsy, Hannah Murray DClinPsy, Alice Kerr DClinPsy, Richard Stott DclinPsy, Alexander Rozental PhD, Prof Gerhard Andersson PhD, Prof David M Clark DPhil, Apostolos Tsiachristas PhD, Prof Anke Ehlers PhD
Although there are effective psychological treatments for post-traumatic stress disorder (PTSD), they remain inaccessible for many people. Digitally enabled therapy is a way to overcome this problem; however, there is little evidence on which forms of these therapies are most cost effective in PTSD. We aimed to assess the cost-effectiveness of the STOP-PTSD trial, which evaluated two therapist-assisted
-
Judy Bass: a global outlook on mental health Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-26 Tony Kirby
-
Mental health implementation research in Latin America and the Caribbean Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-26 Eliut Rivera-Segarra, Franco Mascayano, Ana Florence, July Caballero, Leopoldo J Cabassa
-
Mental health implementation science: integrating lived experience expertise Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-26 Claudia Sartor, Mujtaba Hussian
-
Generating better implementation evidence to improve mental health care everywhere Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-26 Milton L Wainberg, Lidia Gouveia, Karen McKinnon
-
Implementation research in mental health: meanings of the term real world Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-26 Claire Henderson
-
The Lancet Psychiatry Commission: transforming mental health implementation research Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-26 Prof Emma E McGinty PhD, Prof Margarita Alegria PhD, Prof Rinad S Beidas PhD, Prof Jeffrey Braithwaite PhD, Lola Kola PhD, Prof Douglas L Leslie PhD, Nathalie Moise MD, Prof Bernardo Mueller PhD, Prof Harold A Pincus MD, Rahul Shidhaye MD, Prof Kosali Simon PhD, Prof Sara J Singer PhD, Prof Elizabeth A Stuart PhD, Matthew D Eisenberg PhD
-
Establishing a research agenda for the study and assessment of opioid withdrawal Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-20 Prof Kelly E Dunn PhD, Prof Eric C Strain MD
The opioid crisis is an international public health concern. Treatments for opioid use disorder centre largely on the management of opioid withdrawal, an aversive collection of signs and symptoms that contribute to opioid use disorder. Whereas in the past 50 years more than 90 medications have been developed for depression, only five medications have been developed for opioid use disorder during this
-
Why treatment manuals of psychological interventions should be freely available Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-18 Pim Cuijpers, Niall Boyce, Mark van Ommeren
-
Leanne Williams: fighting stigma through imaging Lancet Psychiatry (IF 30.8) Pub Date : 2024-03-13 Talha Burki